Summary
The product Boldenon Undecylenate 200mg/ml, manufactured by REDMOND PHARMACY, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number 20SEMRAF, was submitted by REDMOND PHARMACY and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Boldenone Undecylenate, with a concentration of 214.79 mg/ml, exceeding the labeled claim of 200 mg/ml by 7.4%.
The testing process was conducted on 08 OCT 2024. While the results confirm accurate dosing, further independent validation is recommended to ensure consistency across the product line. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: REDMOND PHARMACY
- Product Name: Boldenon Undecylenate 200mg/ml
- Active Ingredient: Boldenone Undecylenate
- Batch Number: 20SEMRAF
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #50036
- Testing Ordered: 27 September 2024
- Sample Received: 3 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Optitropin.EU (Reseller)
- Analysis Paid For By: Optitropin.EU
Testing Results
- Boldenone Undecylenate Concentration: 214.79 mg/ml
- Accuracy: 107.4% (7.4% above the label claim)
- Variance: +7.4%
Verification Details
- Verification URL: https://janoshik.com/tests/50036_32MY1FRUBCZL
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the accuracy of the tested product, with a measured concentration of 214.79 mg/ml, exceeding the labeled claim by 7.4%. However, manufacturer-submitted samples may not fully represent the consistency of products available in the broader market. Independent third-party testing remains crucial to validate these findings comprehensively.
Conclusion
The analysis confirms that Boldenon Undecylenate 200mg/ml is slightly overdosed, with a measured concentration of 214.79 mg/ml. This result reflects strong quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
